Atlas Trials

Double-Blinded, Placebo-Controlled Phase 1b Study for Safety, PK, Efficacy, PD of RO7049665 in Participants With Ulcerative Colitis (UC)

Clinical trial NCT03943550 · TERMINATED

Trial details

NCT number
NCT03943550
Sponsor
Hoffmann-La Roche
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Ulcerative Colitis
Start date
2019-05-13
Primary completion
2021-07-22
Enrollment
45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.